Quantcast

Latest Julio Palmaz Stories

2010-09-23 08:06:00

TORONTO, Sept. 23 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, Latin American physicians will increasingly adopt abdominal and thoracic endovascular aortic repair in place of surgical repair through 2015 as awareness of the benefits of endovascular techniques grows and physician training improves. Thoracic endovascular aortic repair tends to be a slightly more attractive option for physicians and patients...

2010-08-26 08:00:00

IRVINE, Calif., Aug. 26 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it received CE Mark approval to market its expanded offering of Powerlink® stent graft products and PowerFit(TM) Aortic Extensions in the European Union. The Company expects to launch the products in a limited market release in Europe during the fourth quarter of 2010, followed by a full product launch in...

2010-08-16 10:30:00

IRVINE, Calif., Aug. 16 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has entered into a development agreement and exclusive license with Evasc Medical Systems Corp., for its balloon expandable stent technology. Evasc is a medical device development company located in Vancouver, B.C. The patented stent is made from cobalt chromium and is pre-mounted on an angioplasty balloon catheter for...

2009-12-14 07:07:00

WALTHAM, Mass., Dec. 14 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, Japan's complex regulatory environment and lengthy device approval process has created a significant lag in peripheral vascular stenting device availability in the country compared to other developed nations. MRG's new Japanese Markets for Peripheral Vascular Devices 2010 report finds, however, that recent indication-specific device...

2009-09-21 17:39:00

SAN FRANCISCO, Sept. 21 /PRNewswire/ -- Julio Palmaz, M.D., of Palmaz Scientific, will be seen at next week's Transcatheter Cardiovascular Therapeutics (TCT) Conference in San Francisco as a discussant, presenter and lecturer on Sept. 21-23, during the first three days of the event. Palmaz is the opening lecturer and closing discussant next week during the Coronary Stent Design and Device Development portion of the conference lasting from 2 p.m. to 6 p.m. on Wednesday, Sept 23. He begins...

2009-05-28 09:21:00

Positive clinical data, competitor focus, and new drug-eluting technologies to drive lower extremity procedures in Europe, according to Millennium Research Group WALTHAM, Mass., May 28 /PRNewswire/ -- According to Millennium Research Group's (MRG's) European Markets for Peripheral Vascular (PV) Devices 2009 report, rapid growth in the number of endovascular procedures that treat lower extremity peripheral artery disease in Europe is being fueled by positive clinical trial results, increased...

2008-10-14 09:00:45

Julio Palmaz, M.D. made his mark on the medical world 20 years ago with the invention of the stent which revolutionized cardiac care, and now more than a million people each year undergo coronary artery stenting to repair clogged arteries. Today, Dr. Palmaz leads a team of scientists and high tech engineers at newly established Palmaz Scientific, Inc. on a mission to create safer and more predictable implantable prosthetic devices. Dr. Palmaz and his colleagues will introduce Palmaz...

2008-09-16 12:00:50

Three internationally known pediatric surgeons from The University of Texas Health Science Center at San Antonio and its academic children's hospital, CHRISTUS Santa Rosa Children's Hospital, are this year's recipients of the prestigious Julio Palmaz Award for Innovation in Healthcare and the Biosciences. Robert M. Campbell, Jr., M.D., Melvin D. Smith, M.D. (deceased) and Kaye E. Wilkins, D.V.M., M.D. are each being honored for devising innovative ideas that have had tangible, life-saving...

2005-07-13 11:25:10

CHICAGO (Reuters) - U.S. regulators on Wednesday said they do not plan to take further action against Boston Scientific Corp.'s heart stents despite reports of more injuries related to the devices. Boston Scientific, which commands nearly two-thirds of the lucrative market for drug-eluting stents, last year recalled more than 99,000 Taxus heart stents following reports of malfunctions. This, plus recalls from other major medical device companies, have weighed on the sector. "We do not...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related